Table 1A.
Characteristic | No. (%) | Median Dx Age (yrs) | 95% CI | p-value |
---|---|---|---|---|
Overall | 833 | 33.8 | (32.7, 35.9) | n/a |
| ||||
Gender | 0.937 | |||
Female | 425 (51%) | 33.4 | (31.0, 35.7) | |
Male | 408 (49%) | 34.3 | (31.5, 37.7) | |
| ||||
Ethnicity | <0.001 | |||
Asian / Pacific Islander | 113 (14%) | 29.9 | (25.9, 34.3) | |
Black / African-American | 56 (5%) | 46.5 | (41.2, 50.3) | |
Hispanic | 224 (27%) | 27.0 | (23.4, 29.8) | |
Native American | 9 (1%) | 37.1 | (17.4, 47.1) | |
Non-Hispanic Caucasian | 431 (52%) | 38.7 | (35.3, 42.6) | |
| ||||
Hemorrhagic presentation | <0.001 | |||
Yes | 375 (45%) | 28.7 | (26.6, 32.2) | |
No | 458 (55%) | 37.6 | (35.3, 40.6) | |
| ||||
HHT diagnosis | 0.695 | |||
Yes | 12 (1%) | 38.3 | (1.8, 54.0) | |
No | 821 (99%) | 33.7 | (31.6, 35.8) |
P-values are from log-rank tests of survivor functions.
HHT = hereditary telangiectasia syndrome